These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

102 related articles for article (PubMed ID: 1099553)

  • 1. [Role of fibrinolytic activity in renal pathology].
    Kacprzyk F
    Pol Tyg Lek; 1975 Aug; 30(34):1409-11. PubMed ID: 1099553
    [No Abstract]   [Full Text] [Related]  

  • 2. Origin of urinary fibrin/fibrinogen degradation products in glomerulonephritis.
    Ekberg M; Pandolfi M
    Br Med J; 1975 Apr; 2(5961):17-9. PubMed ID: 48398
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The pathogenetic role of the coagulation process in glomerular diseases of immunologic origin.
    Vassalli P; McCluskey RT
    Adv Nephrol Necker Hosp; 1971; 1():47-63. PubMed ID: 4143241
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Plasma exchange with a membrane filter in glomerulonephritis mediated by antibodies to glomerular basement membrane.
    Krediet RT; Balk AG; Egberts G; Arisz L
    Neth J Med; 1982; 25(8):255-61. PubMed ID: 7144992
    [No Abstract]   [Full Text] [Related]  

  • 5. Fibrin-fibrinogen degradation products in children with renal disease.
    Ambrus JL; Baliah T; Ambrus CM; Mink IB; Murphy GP
    N Y State J Med; 1974 Jul; 74(8):1396-402. PubMed ID: 4277485
    [No Abstract]   [Full Text] [Related]  

  • 6. Macrophage-induced glomerular fibrin deposition in experimental glomerulonephritis in the rabbit.
    Holdsworth SR; Tipping PG
    J Clin Invest; 1985 Oct; 76(4):1367-74. PubMed ID: 4056035
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Fibrin degradation products and fibrinolytic activity in most frequent renal diseases in children].
    Kleniewski J; Oleszkiewicz J
    Pediatr Pol; 1972 Jan; 47(1):49-54. PubMed ID: 5059017
    [No Abstract]   [Full Text] [Related]  

  • 8. Renal cortical fibrinolytic activity in rabbits with chronic immune complex nephritis.
    Stark H; Miller K; Michael AF
    Isr J Med Sci; 1979 Jul; 15(7):610-2. PubMed ID: 158001
    [No Abstract]   [Full Text] [Related]  

  • 9. Role of anti-basement membrane immunity in human glomerulonephritis.
    Bach JF; Dardenne M; Hinglais N; Mahieu P
    Adv Nephrol Necker Hosp; 1972; 2():75-94. PubMed ID: 4219697
    [No Abstract]   [Full Text] [Related]  

  • 10. Clinical application of a radio-immunoassay for auto-antibodies to glomerular basement membrane.
    Bowman C; Lockwood CM
    J Clin Lab Immunol; 1985 Aug; 17(4):197-202. PubMed ID: 4068032
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Characterization and significance of urinary fibrin degradation products.
    Cortes P; Potter EV; Kwaan HC
    J Lab Clin Med; 1973 Sep; 82(3):377-89. PubMed ID: 4199524
    [No Abstract]   [Full Text] [Related]  

  • 12. Fibrin deposition and adaptive changes in glomerular procoagulant and fibrinolytic activities in rat renoprival nephropathy.
    Ruedin P; Mougenot B; Ruedin D; Rondeau E; Sraer JD; Lacave R; Kanfer A
    J Exp Pathol (Oxford); 1990 Apr; 71(2):269-78. PubMed ID: 2331409
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Glomerular anti-basal membrane cell-mediated immune response in nephropathies].
    Németh L; Gofman L; Hámori A
    Orv Hetil; 1982 Jan; 123(4):211-8. PubMed ID: 7063239
    [No Abstract]   [Full Text] [Related]  

  • 14. Immune complex-mediated glomerulonephritis is ameliorated by thrombin-activatable fibrinolysis inhibitor deficiency.
    Bruno NE; Yano Y; Takei Y; Qin L; Suzuki T; Morser J; D'Alessandro-Gabazza CN; Mizoguchi A; Suzuki K; Taguchi O; Gabazza EC; Sumida Y
    Thromb Haemost; 2008 Jul; 100(1):90-100. PubMed ID: 18612543
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The role of coagulation in renal disease.
    MacDonald MK; Clarkson AR; Davison AM
    Perspect Nephrol Hypertens; 1973; 1 Pt 2(0):809-28. PubMed ID: 4807810
    [No Abstract]   [Full Text] [Related]  

  • 16. Successful renal transplantation in patients with circulating antibodies to glomerular basement membrane.
    Couser WG; Monaco AP; Lewis EJ
    Proc Clin Dial Transplant Forum; 1973; 3():208-10. PubMed ID: 4619684
    [No Abstract]   [Full Text] [Related]  

  • 17. [Effect of the administration of heparin on the urinary excretion of fibrinogen-like antigens in glomerular nephropathies].
    L'Abbate A; Ciccarelli C; Poggi A; Maggiore Q
    Minerva Nefrol; 1974; 21(3):141-6. PubMed ID: 4463294
    [No Abstract]   [Full Text] [Related]  

  • 18. Urinary fibrin-fibrinogen degradation products (FDP) and glomerulonephritis.
    Hedner U; Ekberg M; Nilsson IM
    Acta Med Scand; 1974; 195(1-2):81-5. PubMed ID: 4817097
    [No Abstract]   [Full Text] [Related]  

  • 19. Recurrent glomerulonephritis due to anti-glomerular basement membrane-antibodies in two successive allografts.
    Beleil OM; Coburn JW; Shinaberger JH; Glassock RJ
    Clin Nephrol; 1973; 1(6):377-80. PubMed ID: 4594999
    [No Abstract]   [Full Text] [Related]  

  • 20. [Necrotizing glomerulonephritis with linear fixation along the glomerular basement membranes (GBM) without circulating anti-GBM antibodies].
    Ganeval D; Commare MC; Droz D; Noël LH; Grünfeld JP
    Nephrologie; 1985; 6(3):163-4. PubMed ID: 4080077
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.